PetMed Express Q1 Adj $0.03 Misses $0.07 Estimate, Sales $78.24M Miss $79.44M Estimate
Portfolio Pulse from Benzinga Newsdesk
PetMed Express reported Q1 losses of $(0.04) per share, missing the analyst consensus estimate of $0.07 by 157.14%. This is a 128.57% decrease from the same period last year. The company also reported quarterly sales of $78.24 million, missing the estimate of $79.44 million by 1.51%. However, this is an 11.48% increase from the same period last year.
July 31, 2023 | 8:46 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
PetMed Express reported a significant miss in Q1 earnings and a slight miss in sales. However, sales have increased compared to the same period last year.
The company reported a significant miss in earnings, which is a key factor for investors. This could negatively impact the stock price in the short term. However, the increase in sales compared to the same period last year could potentially offset some of the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100